Post Profile






ME affects four times as many women as men. Is that why we’re still disbelieved? | Nathalie Wright

Sexism is part of the reason why people with ME struggle to get diagnosed and treated. We need more funding for research into this disabling condition Today friends and families of people with ME are taking to the streets of cities around the world to call for more funding for medical research and education about ME. I am joining them at the London demonstration of the Millions Missing campaign, outside the Department of Health.
read more

share

Related Posts


So Your Kid Just Got Diagnosed with a Disability: 5 Tips for What You Do Next

Lifestyle : xoJane

My son was diagnosed with three medical conditions in the first four years of his life. Not a solitary condition – they weren't wrong two times and then right once – but an additional condition each year. A clotting condition at 10 ...

Anxiety Disorders Diagnosed More Often in Women Than Men

Health : Wall Street Journal Health Blog

Women are twice as likely as men to be diagnosed with anxiety disorders—and the reasons range from hormonal fluctuations to brain chemistry to upbringing to empathy, researchers theorize.

African-American Couples Have Unmet Needs when Family Affected by Prostate Cancer

Health : Newswise Medical News

Researchers at Moffitt Cancer Center have found that in African-American families where men are diagnosed with prostate cancer, they have unmet psychosocial needs that affect their survivorship, as well as family and social relation...

Three Times More Women Than Men Suffer From Arthritis: Study Reveals Insights Into This Gender Bias

Health : Medical News Today

Researchers have pieced together new genetic clues to the arthritis puzzle in a study that brings potential treatments closer to reality and could also provide insights into why more women than men succumb to the disabling condition...

Amgen's multiple myeloma drug falls short in late stage study

Health : Reuters: Health

(Reuters) - Amgen Inc said on Tuesday its cancer drug Kyprolis failed to meet the main goal of a late-stage study against Takeda Pharmaceutical Co Ltd's Velcade for treating newly diagnosed multiple myeloma.

Comments


Copyright © 2016 Regator, LLC